Cargando…
Targeting SARS‐CoV‐2 with Chaga mushroom: An in silico study toward developing a natural antiviral compound
The novel coronavirus (SARS‐CoV‐2) has caused large‐scale global outbreaks and mainly mediates host cell entry through the interaction of its spike (S) protein with the human angiotensin‐converting enzyme‐2 (ACE‐2) receptor. As there is no effective treatment for SARS‐CoV‐2 to date, it is imperative...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645752/ https://www.ncbi.nlm.nih.gov/pubmed/34900242 http://dx.doi.org/10.1002/fsn3.2576 |